Speaker illustration

Doctor Olga Shahmatova

National Medical Research Center of Cardiology, Moscow (Russian Federation)

Prognostic impact of proton pump inhibitors in patients after elective percutaneous coronary intervention with implantation of second-generation drug eluting stents

Event: EuroPrevent 2019

Topic: Cardiovascular Pharmacotherapy

Session: Cardiovascular Pharmacotherapy

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb